Jannasch Olof, Schwanz Martin, Otto Ronny, Mik Michal, Lippert Hans, Mroczkowski Pawel
Department for Visceral Vascular and Emergency Surgery and VIGO, Municipial Hospital Magdeburg, 39130 Magdeburg, Germany.
Institute for Quality Assurance in Operative Medicine Ltd., Otto-von-Guericke-University Magdeburg, 39106 Magdeburg, Germany.
Cancers (Basel). 2025 Jan 27;17(3):414. doi: 10.3390/cancers17030414.
Lymphadenectomy is a fundamental part of surgical strategy in patients with gastric cancer. Lymph node (LN) status is a key point in assessment of prognosis in gastric cancer. The LN ratio (LNR)-number of positive LNs/number of sampled LNs-offers a new approach for predicting survival. The aim of the study was to find factors affecting LN yield and the impact of LNR on 5-year survival.
Prospective multicenter quality assurance study. Only LN-positive patients were included in the LNR calculations.
4946 patients from 149 hospitals were enrolled. The inclusion criteria were met by 1884 patients. Patients were divided into two groups: Group 1 (<16 LN), 456 patients and Group 2 (≥16 LN), 1428 patients. The multivariate analysis found G2 (OR 1.98; 95%CI 1.11-3.54), G3 (OR 2.15; 95%CI 1.212-3.829), UICC-stage II (OR 1.44; 95%CI 1.01-2.06) and III (OR 1.71; 95%CI 1.14-2.57), age < 70 (OR 1.818 95%CI 1.19-2.78) and female gender (OR 1.37; 95%CI 1.00-1.86) as independent factors of ≥16 LN yield. Patients with a LNR ≥ 0.4 have a lower probability of survival ( = 0.039 and <0.001) than patients with a LNR = 0.1. Patients with UICC-II have a lower probability of survival than UICC-I ( = 0.023). Age 70-80 ( = 0.045) and > 80 years ( = 0.003) were negative prognostic factors for long-term survival.
Long-term survival is directly related to adequate lymphadenectomy. LNR could be superior to pN-stage for estimating survival and adds remarkable nuances in prognosis compared to UICC-stage. LNR also appears valid, even in the case of insufficient LN yield.
淋巴结清扫术是胃癌患者手术策略的基本组成部分。淋巴结(LN)状态是评估胃癌预后的关键因素。淋巴结比率(LNR)——阳性淋巴结数量/采样淋巴结数量——为预测生存提供了一种新方法。本研究的目的是找出影响淋巴结获取量的因素以及LNR对5年生存率的影响。
前瞻性多中心质量保证研究。LNR计算仅纳入淋巴结阳性患者。
来自149家医院的4946例患者入组。1884例患者符合纳入标准。患者分为两组:第1组(<16个淋巴结),456例患者;第2组(≥16个淋巴结),1428例患者。多因素分析发现,G2(比值比[OR]1.98;95%置信区间[CI]1.11 - 3.54)、G3(OR 2.15;95%CI 1.212 - 3.829)、国际抗癌联盟(UICC)II期(OR 1.44;95%CI 1.01 - 2.06)和III期(OR 1.71;95%CI 1.14 - 2.57)、年龄<70岁(OR 1.818,95%CI 1.19 - 2.78)以及女性(OR 1.37;95%CI 1.00 - 1.86)是≥16个淋巴结获取量的独立影响因素。LNR≥0.4的患者比LNR = 0.1的患者生存概率更低(P = 0.039,P<0.001)。UICC-II期患者比UICC-I期患者生存概率更低(P = 0.023)。70 - 80岁(P = 0.045)和>80岁(P = 0.003)是长期生存的不良预后因素。
长期生存与充分的淋巴结清扫术直接相关。LNR在估计生存方面可能优于pN分期,并且与UICC分期相比,在预后方面增加了显著的细微差别。即使在淋巴结获取量不足的情况下,LNR似乎也是有效的。